Trial-Ready Cohort-Down Syndrome (TRC-DS)

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
University of Southern California
Study ID
NCT04165109
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
25 Years - 55 Years
Healthy Volunteers
Not accepted

Study Details

The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC), and up to 550 participants in total including co-enrolled in the Alzheimer Biomarkers Consortium - Down Syndrome (ABC-DS) study. Participants enrolled in the TRC-DS will undergo longitudinal cognitive and clinical assessment, genetic and biomarker testing, as well as imaging and biospecimen collection. Using these outcome measures, researchers will analyze the relationships between cognitive measures and biomarkers of Alzheimer's disease (AD) to identify endpoints for AD clinical trials in DS that best reflect disease progression. To learn more about the study and participating sites, visit our study website at: https://www.trcds.org/. TRC-DS is collaborating with the Alzheimer's Disease Biomarker Consortium-Down Syndrome (ABC-DS) to allow study participants to be concurrently enrolled in both ABC-DS and TRC-DS, referred to as "co-enrollment". ABC-DS is a longitudinal, observational research study that is overseen at University of Pittsburgh Coordinating Center. ABC-DS participants who express interest in potentially joining a clinical trial in the future and who meet TRC-DS eligibility criteria, may choose to co-enroll in TRC-DS at an ABC-DS Site. Co-enrolled participants will adhere to the ABC-DS protocol and schedule of activities, but agree to share their data with the TRC-DS team and to receive invitations for future participation in clinical trials. Fore more information on ABC-DS please visit https://www.nia.nih.gov/research/abc-ds or http://abcds.pitt.edu/.

Key Dates

Start date
Jun 7, 2021
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
550 participants (estimated)

Arms

  • Arm: Trial Ready Cohort
    Non-demented adults with Down syndrome (DS)

Primary Outcome Measure

Enrollment of participants into the Trial-Ready Cohort in DS (TRC-DS). [ Time Frame: 5 years ]

Central Contacts

Locations (18)

FacilityCityStateZIPSite coordinators
Barrow Neurological InstitutePhoenixArizona85013
Anna Burke, MD (PRINCIPAL_INVESTIGATOR)
University of California, Irvine School of Medicine, Co-Enrolling through ABC-DS OnlyOrangeCalifornia92868
Ira Lott (PRINCIPAL_INVESTIGATOR)
Linda Crnic Institute for Down Syndrome, University of ColoradoAuroraColorado80045
Joaquin Espinosa, PhD (PRINCIPAL_INVESTIGATOR)
Advocate Medical Group Adult Down Syndrome CenterPark RidgeIllinois60068
Brian Chicoine, MD (PRINCIPAL_INVESTIGATOR)
Indiana UniversityIndianapolisIndiana46202
Jill Fodstad, PhD (PRINCIPAL_INVESTIGATOR)
University of Kansas Medical CenterKansas CityKansas66160
Lauren T Ptomey, PhD, RD, LD (PRINCIPAL_INVESTIGATOR)
University of Kentucky, Co-Enrolling through ABC-DS OnlyLexingtonKentucky40504
Frederick Schmitt, PhD (PRINCIPAL_INVESTIGATOR)
Massachusetts General Hospital, Co-Enrolling through ABC-DS OnlyBostonMassachusetts02114
Herminia Herminia Diana Rosas (PRINCIPAL_INVESTIGATOR)
Washington University, St. LouisSt LouisMissouri63108
Beau Ances, MD, PhD (PRINCIPAL_INVESTIGATOR)
Cleveland Clinic, Lou Ruvo Center for Brain Health, Las VegasLas VegasNevada89106
Charles Bernick, MD (PRINCIPAL_INVESTIGATOR)
New York State Institute for Basic Research in Developmental Disabilities (SIBRDD), Co-Enrolling through ABC-DS OnlyStaten IslandNew York10314
Sharon Krinsky-McHale, PhD (PRINCIPAL_INVESTIGATOR)
Case Western Reserve UniversityBeachwoodOhio44122
Rajeet Shrestha, MD (PRINCIPAL_INVESTIGATOR)
University of CincinnatiCincinnatiOhio45219
Russell Sawyer, MD (PRINCIPAL_INVESTIGATOR)
Oregon Health & Science UniversityPortlandOregon97239
Aimee Pierce, MD (PRINCIPAL_INVESTIGATOR)
University of Pittsburgh, Co-Enrolling through ABC-DS OnlyPittsburghPennsylvania15213
Benjamin Handen (PRINCIPAL_INVESTIGATOR)
Vanderbilt University Medical Center Center for Cognitive MedicineNashvilleTennessee37212
Paul Newhouse, MD (PRINCIPAL_INVESTIGATOR)
University of Texas Health San Antonio, Glenn Biggs Institute for Alzheimer's & Neurodegenerative DiseasesSan AntonioTexas78229
Sarah Savoia, PAC-C (PRINCIPAL_INVESTIGATOR)
University of Wisconsin - Madison, Waisman Center, Co-Enrolling through ABC-DS OnlyMadisonWisconsin53705
Bradley Christian (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

Related Studies